chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: FEELING CRAPPY; This spontaneous report received from a vaccine facility via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown, and batch number: UNKNOWN expiry: UNKNOWN) .5 ml, administered on 10-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 10-MAR-2021, the subject experienced feeling crappy. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of feeling crappy was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Injection site pain, Myalgia
Clinical narrative: MODERATE PAIN IN THE RIGHT ARM WHERE PATIENT GOT INJECTED; MUSCLE SORENESS; TIREDNESS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown, and batch number: UNKNOWN expiry: UNKNOWN) .5 ml, administered on 07-MAR-2021 to Right Arm for prophylactic vaccination. The batch number was not reported and had been requested. No concomitant medications were reported. On MAR-2021, the subject experienced tiredness. On 08-MAR-2021, the subject experienced muscle soreness. On 09-MAR-2021, the subject experienced moderate pain in the right arm where subject got injected. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from tiredness on 08-MAR-2021, and muscle soreness on 09-MAR-2021, and had not recovered from moderate pain in the right arm where patient got injected. This report was non-serious.
Sex: U
Vaccine: COVID19, UNK
Symptoms: Pain, Pyrexia
Clinical narrative: LOW GRADE FEVER; BODY ACHES; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular and batch number: UNKNOWN expiry: UNKNOWN) .5 ml, start therapy date was not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 09-MAR-2021, the subject experienced low grade fever. On 09-MAR-2021, the subject experienced body aches. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the low grade fever and body aches was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Incorrect dose administered by device, Syringe issue
Clinical narrative: PARTIAL DOSE GIVEN; FAULTY NEEDLE/SYRINGE; This spontaneous report received from a pharmacist concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1802072, and batch number: 1802072 expiry: UNKNOWN) .5 ml, administered on 11-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 11-MAR-2021, the subject experienced partial dose given. On 11-MAR-2021, the subject experienced faulty needle/syringe. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the partial dose given and faulty needle/syringe was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Diarrhoea, Headache, Polymerase chain reaction, Pyrexia
Clinical narrative: DIARRHEA; VOMITING; FEVER; FEELING WEAK; HEADACHE; This spontaneous report received from a consumer concerned a 60 year old white Not Hispanic/Latino female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805022, and expiry: not reported) .5 ml, administered on 07-MAR-2021 to Left Arm for prophylactic vaccination. No concomitant medications were reported. On 15-JAN-2021, Laboratory data included: PCR (NR: not provided) negative. On 08-MAR-2021, the subject experienced fever. On 08-MAR-2021, the subject experienced feeling weak. On 08-MAR-2021, the subject experienced headache. On 11-MAR-2021, the subject experienced diarrhea. On 11-MAR-2021, the subject experienced vomiting. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fever, and headache, had not recovered from diarrhea, and vomiting, and the outcome of feeling weak was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: DIARRHEA; VOMITING; FEVER; FEELING WEAK; HEADACHE; This spontaneous report received from a consumer concerned a 60 year old white Not Hispanic/Latino female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805022, and expiry: not reported) .5 ml, administered on 07-MAR-2021 to Left Arm for prophylactic vaccination. No concomitant medications were reported. On 15-JAN-2021, Laboratory data included: PCR (NR: not provided) negative. On 08-MAR-2021, the subject experienced fever. On 08-MAR-2021, the subject experienced feeling weak. On 08-MAR-2021, the subject experienced headache. On 11-MAR-2021, the subject experienced diarrhea. On 11-MAR-2021, the subject experienced vomiting. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fever, and headache, had not recovered from diarrhea, and vomiting, and the outcome of feeling weak was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Headache, Lacrimation increased, Vision blurred
Clinical narrative: BLURRY VISION FOR 15-20 MINUTES; FELT SPACEY; WATERY EYES; OCCULAR HEADACHE; This spontaneous report received from a patient concerned a 68 year old female. The patient's height, and weight were not reported. The patient's past medical history included occular headache, and chronic lymes disease, and other pre-existing medical conditions included patient had no known allergy.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805022, expiry: 25-MAY-2021) dose was not reported, administered on 11-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 11-MAR-2021, the patient experienced blurry vision for 15-20 minutes, felt spacey, watery eyes and occular headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from blurry vision for 15-20 minutes, felt spacey, and watery eyes on 11-MAR-2021, and the outcome of occular headache was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment is not required as per standard procedure as the case is non serious
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pyrexia
Clinical narrative: CHILLS; FEVER; This spontaneous report received from a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown, and batch number: UNKNOWN expiry: UNKNOWN) .5 ml, administered on 10-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 10-MAR-2021 10:00, the subject experienced chills. On 10-MAR 2021 10:00, the subject experienced fever 101.8f. Laboratory data included: Body temperature increased (NR: not provided) 101.F F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the chills and fever 101.8f was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Diarrhoea, Nausea
Clinical narrative: DIARRHEA; NAUSEA; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805022, and batch number: 1805022 expiry: UNKNOWN) .5 ml, administered on 08-MAR-2021 to Left Deltoid for prophylactic vaccination. No concomitant medications were reported. On 11-MAR-2021, the subject experienced diarrhea. On 11-MAR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from nausea on MAR-2021, and had not recovered from diarrhea. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Injection site pain
Clinical narrative: SORE SHOULDER; SORE ARM OF INJECTION SITE; TIRED AFTER RECEIVING VACCINE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805020, and batch number: 1805020 expiry: UNKNOWN) dose was not reported, administered on 09-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-MAR-2021, the subject experienced sore shoulder. On 09-MAR-2021, the subject experienced sore arm of injection site. On 09-MAR-2021, the subject experienced tired after receiving vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from sore shoulder, sore arm of injection site, and tired after receiving vaccine. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Bone pain, Chills, Lethargy, Pyrexia
Clinical narrative: LETHARGIC; CHILLS; FEVER; BONE ACHINESS; This spontaneous report received from a patient via a company representative concerned a 48 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patent had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1804025, and batch number: 1804025 expiry: UNKNOWN) .5 ml, administered on 10-MAR-2021 14:30 for prophylactic vaccination. No concomitant medications were reported. On 10-MAR-2021, the subject experienced bone achiness. On 10-MAR-2021, the subject experienced chills. On 10-MAR-2021, the subject experienced fever. On 11-MAR-2021, the subject experienced lethargic. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from bone achiness, and chills on 11-MAR-2021, was recovering from fever, and had not recovered from lethargic. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Nausea
Clinical narrative: FREEZING; NAUSEA; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) .5 ml, administered on 11-MAR-2021 03:00 for prophylactic vaccination.The batch number was not reported and has been requested.  No concomitant medications were reported. On 11-MAR-2021, the patient experienced freezing. On 11-MAR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from freezing, and nausea. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Heart rate increased, Influenza, Myalgia, Pain
Clinical narrative: EXTREMELY RAPID HEARTBEAT; MUSCLE ACHES; FLU; PAIN CONSISTENT; This spontaneous report received from a patient concerned a 65 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown, and batch number: UNKNOWN expiry: UNKNOWN) .5 ml, administered on 09-MAR-2021 14:30 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the subject experienced muscle aches. On MAR-2021, the subject experienced flu. On MAR-2021, the subject experienced pain consistent. On 10-MAR-2021, Laboratory data included: Heart rate (NR: not provided) 102 {beats}/min. On 10-MAR-2021 05:00, the subject experienced extremely rapid heartbeat. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from extremely rapid heartbeat on 10-MAR-2021 21:00, and the outcome of muscle aches, flu and pain consistent was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Hypersomnia
Clinical narrative: TIRED; SLEEPING A LOT; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular and batch number: 1805022 expiry: UNKNOWN) .5 ml, administered on 09-MAR-2021 to Left Arm for prophylactic vaccination. No concomitant medications were reported. On 09-MAR-2021, the subject experienced tired. On 09-MAR-2021, the subject experienced sleeping a lot. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from tired, and sleeping a lot. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chest pain, Chills, Cough, Facial pain
Clinical narrative: BURNING SENSATION IN CHEST; HEADACHE; FEVER; CHILLS; NAUSEA; FATIGUE; DRY COUGH; JAW AND CHEEKS HURT; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included donated blood, and donated blood, and concurrent conditions included penicillin allergy, and sulfonamide allergy.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805018, and batch number: 1805018 expiry: 25-MAY-2021) .5 ml, administered on 09-MAR-2021 10:20 for prophylactic vaccination. No concomitant medications were reported. On DEC-2020, Laboratory data included: COVID-19 virus test (NR: not provided) NEGATIVE. On MAR-2021, the subject experienced dry cough. On MAR-2021, the subject experienced jaw and cheeks hurt. On 09-MAR-2021, the subject experienced nausea. On 09-MAR-2021, the subject experienced fatigue. On 09-MAR-2021 21:00, the subject experienced chills. On 09-MAR-2021 22:00, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 101.3 F. On 10-MAR-2021, the subject experienced burning sensation in chest. On 10-MAR-2021, the subject experienced headache. Treatment medications included: ibuprofen. Laboratory data (dates unspecified) included: COVID-19 antibody test (NR: not provided) NEGATIVE. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from burning sensation in chest, and nausea on 10-MAR-2021, and fatigue on MAR-2021, was recovering from fever, chills, and headache, and the outcome of dry cough and jaw and cheeks hurt was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea, Pyrexia, SARS-CoV-2 antibody test
Clinical narrative: BURNING SENSATION IN CHEST; HEADACHE; FEVER; CHILLS; NAUSEA; FATIGUE; DRY COUGH; JAW AND CHEEKS HURT; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included donated blood, and donated blood, and concurrent conditions included penicillin allergy, and sulfonamide allergy.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805018, and batch number: 1805018 expiry: 25-MAY-2021) .5 ml, administered on 09-MAR-2021 10:20 for prophylactic vaccination. No concomitant medications were reported. On DEC-2020, Laboratory data included: COVID-19 virus test (NR: not provided) NEGATIVE. On MAR-2021, the subject experienced dry cough. On MAR-2021, the subject experienced jaw and cheeks hurt. On 09-MAR-2021, the subject experienced nausea. On 09-MAR-2021, the subject experienced fatigue. On 09-MAR-2021 21:00, the subject experienced chills. On 09-MAR-2021 22:00, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 101.3 F. On 10-MAR-2021, the subject experienced burning sensation in chest. On 10-MAR-2021, the subject experienced headache. Treatment medications included: ibuprofen. Laboratory data (dates unspecified) included: COVID-19 antibody test (NR: not provided) NEGATIVE. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from burning sensation in chest, and nausea on 10-MAR-2021, and fatigue on MAR-2021, was recovering from fever, chills, and headache, and the outcome of dry cough and jaw and cheeks hurt was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: BURNING SENSATION IN CHEST; HEADACHE; FEVER; CHILLS; NAUSEA; FATIGUE; DRY COUGH; JAW AND CHEEKS HURT; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included donated blood, and donated blood, and concurrent conditions included penicillin allergy, and sulfonamide allergy.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805018, and batch number: 1805018 expiry: 25-MAY-2021) .5 ml, administered on 09-MAR-2021 10:20 for prophylactic vaccination. No concomitant medications were reported. On DEC-2020, Laboratory data included: COVID-19 virus test (NR: not provided) NEGATIVE. On MAR-2021, the subject experienced dry cough. On MAR-2021, the subject experienced jaw and cheeks hurt. On 09-MAR-2021, the subject experienced nausea. On 09-MAR-2021, the subject experienced fatigue. On 09-MAR-2021 21:00, the subject experienced chills. On 09-MAR-2021 22:00, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 101.3 F. On 10-MAR-2021, the subject experienced burning sensation in chest. On 10-MAR-2021, the subject experienced headache. Treatment medications included: ibuprofen. Laboratory data (dates unspecified) included: COVID-19 antibody test (NR: not provided) NEGATIVE. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from burning sensation in chest, and nausea on 10-MAR-2021, and fatigue on MAR-2021, was recovering from fever, chills, and headache, and the outcome of dry cough and jaw and cheeks hurt was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Injection site bruising, Injection site haemorrhage, Product administration error
Clinical narrative: 1/8 TSP BLOOD AT INJECTION SITE; SMALL BRUISE; PERHAPS THE VACCINE WAS INADVERTENTLY ADMINISTERED SUBCUTANEOUSLY BECAUSE OF THE BLOOD STAINED COTTON; This spontaneous report received from a patient via a company representative concerned a 68 year old female. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) .5 ml, administered on 06-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. Concomitant medications included cyanocobalamin.  On 06-MAR-2021, the patient experienced 1/8 tsp blood at injection site, small bruise and perhaps the vaccine was inadvertently administered subcutaneously because of the blood stained cotton. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the 1/8 tsp blood at injection site, small bruise and perhaps the vaccine was inadvertently administered subcutaneously because of the blood stained cotton was not reported. This report was non-serious. This case, from the same reporter is linked to 20210323322.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Nausea, Pyrexia
Clinical narrative: CHILLS; NAUSEA; FEVER; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown, and batch number: UNKNOWN expiry: UNKNOWN) .5 ml, administered on 10-MAR-2021 09:00 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 10-MAR-2021 18:00, the subject experienced chills. On 10-MAR-2021 18:00, the subject experienced nausea. On 10-MAR-2021 18:00, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from chills, nausea, and fever. This report was non-serious.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysgeusia, Thirst
Clinical narrative: METALLIC TASTE; THIRSTY; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown, and batch number: UNKNOWN expiry: UNKNOWN) .5 ml, administered on 11-MAR-2021 03:00 to Left Deltoid for prophylactic vaccination. The batch number was not reported and had been requested. No concomitant medications were reported. On 11-MAR-2021 05:00, the subject experienced metallic taste. On 11-MAR-2021 05:00, the subject experienced thirsty. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from metallic taste, and thirsty. This report was non-serious.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysgeusia, Fatigue, Lip dry, Thirst
Clinical narrative: METALLIC TASTE; THIRSTY; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown, and batch number: UNKNOWN expiry: UNKNOWN) .5 ml, administered on 11-MAR-2021 03:00 to Left Deltoid for prophylactic vaccination. The batch number was not reported and had been requested. No concomitant medications were reported. On 11-MAR-2021 05:00, the subject experienced metallic taste. On 11-MAR-2021 05:00, the subject experienced thirsty. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from metallic taste, and thirsty. This report was non-serious.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysgeusia, Thirst
Clinical narrative: LIPS DRY; METALLIC TASTE; FATIGUE; MORE THIRSTY THAN USUAL; This spontaneous report received from a patient concerned a 59 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included alcoholic, and non smoker, and other pre-existing medical conditions included no drug abuse/ illicit drug used. The patient was previously treated with benzylpenicillin. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805022, and batch number: 1805022 expiry: UNKNOWN) 0 .5 ml, administered on 11-MAR-2021 03:00 pm for prophylactic vaccination. No concomitant medications were reported. On 11-MAR-2021, the subject experienced fatigue. On 11-MAR-2021, the subject experienced more thirsty than usual. On 11-MAR-2021, the subject experienced metallic taste. On 13-MAR-2021, the subject experienced lips dry. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from metallic taste on 11-MAR-2021, and had not recovered from fatigue, more thirsty than usual, and lips dry. This report was non-serious.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysgeusia, Fatigue, Lip dry, Thirst
Clinical narrative: LIPS DRY; METALLIC TASTE; FATIGUE; MORE THIRSTY THAN USUAL; This spontaneous report received from a patient concerned a 59 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included alcoholic, and non smoker, and other pre-existing medical conditions included no drug abuse/ illicit drug used. The patient was previously treated with benzylpenicillin. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805022, and batch number: 1805022 expiry: UNKNOWN) 0 .5 ml, administered on 11-MAR-2021 03:00 pm for prophylactic vaccination. No concomitant medications were reported. On 11-MAR-2021, the subject experienced fatigue. On 11-MAR-2021, the subject experienced more thirsty than usual. On 11-MAR-2021, the subject experienced metallic taste. On 13-MAR-2021, the subject experienced lips dry. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from metallic taste on 11-MAR-2021, and had not recovered from fatigue, more thirsty than usual, and lips dry. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain
Clinical narrative: TIRED; BODY ACHES; This spontaneous report received from a patient concerned a 50 year old, male.  The patient's height, and weight were not reported. The patient's concurrent conditions included diabetes, abstains from alcohol, and non-smoker, and other pre-existing medical conditions included patient had no abuse drug/ illicit use and known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805031, and batch number: 1805031 expiry: UNKNOWN) dose was not reported, administered on 10-MAR-2021 to Left Arm for prophylactic vaccination. No concomitant medications were reported. On 11-MAR-2021, the patient experienced tired. On 11-MAR-2021, the patient experienced body aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from tired, and body aches. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Migraine
Clinical narrative: MIGRAINE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 10-MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company was unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 10-MAR-2021, the subject experienced migraine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from migraine. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, Injection site extravasation
Clinical narrative: VACCINE POURED DOWN THE ARM  WHEN NEEDLE REMOVED; PULLED OUT THE NEEDLE THE VACCINE POURED OUT STREAMING DOWN  HER ARM; This spontaneous report received from a patient concerned an adult female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: UNKNOWN) .5 ml, administered on 05-MAR-2021 to Left Arm for prophylactic vaccination. The batch number was not reported.  The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced vaccine poured down the arm when needle removed, and pulled out the needle the vaccine poured out streaming down her arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the vaccine poured down the arm when needle removed and pulled out the needle the vaccine poured out streaming down her arm was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Pain in extremity, Pyrexia
Clinical narrative: HEADACHE; FEVER OF 101.7; ARM PAIN WHICH FEELS NERVE DAMAGE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown, and batch number: UNKNOWN expiry: UNKNOWN) .5 ml, administered on 2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 2021, the subject experienced headache. On 2021, the subject experienced fever of 101.7. On 2021, the subject experienced arm pain which feels nerve damage.  On 11-MAR-2021, Laboratory data included: Body temperature (NR: not provided) 101.7 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headache, fever of 101.7 and arm pain which feels nerve damage was not reported. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Hypersomnia, Injection site pain
Clinical narrative: FEELING OFF/NOT AS PRODUCTIVE AS USUAL; FELL ASLEEP; MILD FATIGUE; SORENESS IN ARM AT INJECTION SITE; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient does not normally need to lay down and nap heavily; described as only in dozing mode when napping. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805022, expiry: UNKNOWN) dose was not reported, administered on 06-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 06-MAR-2021, the subject experienced soreness in arm at injection site. On 07-MAR-2021, the subject experienced feeling off/not as productive as usual. On 07-MAR-2021, the subject experienced fell asleep. On 07-MAR-2021, the subject experienced mild fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from feeling off/not as productive as usual, fell asleep, and mild fatigue on 09-MAR-2021, and was recovering from soreness in arm at injection site. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pain, Paraesthesia
Clinical narrative: CHILLS; BODY ACHES; HEADACHE; Fatigue; TINGLING IN BOTH HANDS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805025, expiry: UNKNOWN) dose was not reported, administered on 08-MAR-2021 to right deltoid for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, the subject experienced tingling in both hands. On MAR-2021, the subject experienced fatigue. Treatment medications included: ibuprofen. On 08-MAR-2021, the subject experienced chills. On 08-MAR-2021, the subject experienced body aches. On 08-MAR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from tingling in both hands, and fatigue on MAR-2021, and chills, body aches, and headache on 08-MAR-2021. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Abdominal pain upper, Arthralgia, Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: STOMACH PAIN; PAIN IN TOES; PAIN IN FINGERS; PAIN IN JOINTS; SWELLING AROUND INJECTION SITE; REDNESS AT INJECTION SITE; ITCHY RASH AT INJECTION SITE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's concurrent conditions included rheumatoid arthritis, asthma, and inflammatory bowel disease. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1805031 expiry: UNKNOWN) dose was not reported, administered on 10-MAR-2021 at 10 AM for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, the subject experienced itchy rash at injection site. On MAR-2021, the subject experienced pain in toes. On MAR-2021, the subject experienced pain in fingers. On MAR-2021, the subject experienced pain in joints. On MAR-2021, the subject experienced swelling around injection site. On MAR-2021, the subject experienced redness at injection site. On 10-MAR-2021, the subject experienced stomach pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from stomach pain, was recovering from pain in fingers, and had not recovered from swelling around injection site, pain in toes, pain in joints, redness at injection site, and itchy rash at injection site. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Pain, Pain in extremity
Clinical narrative: STOMACH PAIN; PAIN IN TOES; PAIN IN FINGERS; PAIN IN JOINTS; SWELLING AROUND INJECTION SITE; REDNESS AT INJECTION SITE; ITCHY RASH AT INJECTION SITE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's concurrent conditions included rheumatoid arthritis, asthma, and inflammatory bowel disease. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1805031 expiry: UNKNOWN) dose was not reported, administered on 10-MAR-2021 at 10 AM for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, the subject experienced itchy rash at injection site. On MAR-2021, the subject experienced pain in toes. On MAR-2021, the subject experienced pain in fingers. On MAR-2021, the subject experienced pain in joints. On MAR-2021, the subject experienced swelling around injection site. On MAR-2021, the subject experienced redness at injection site. On 10-MAR-2021, the subject experienced stomach pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from stomach pain, was recovering from pain in fingers, and had not recovered from swelling around injection site, pain in toes, pain in joints, redness at injection site, and itchy rash at injection site. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Eating disorder, Nausea, Pyrexia, Vomiting
Clinical narrative: THROWING UP; NOT EATING; NAUSEOUS; FEVER; This spontaneous report received from a consumer concerned a 20 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included skin tags under patient's arm, and other pre-existing medical conditions included the patient had no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1802070, and batch number: 1802070 expiry: UNKNOWN) .5 ml, administered on 11-MAR-2021 08:15 for prophylactic vaccination. No concomitant medications were reported. On 11-MAR-2021, the subject experienced throwing up. On 11-MAR-2021, the subject experienced not eating. On 11-MAR-2021, the subject experienced nauseous. On 11-MAR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 96.5 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from nauseous, throwing up, not eating, and fever. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Back pain, Chest pain, Injection site pain, Neck pain, Pain
Clinical narrative: BODY ACHES; INJECTION SITE ARM PAIN; PAIN IN FINGERTIPS; NECK PAIN; CHEST PAIN; BACK PAIN; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802070, and batch number: 1802070 expiry: UNKNOWN) dose was not reported, once a total in left deltoid administered on 10-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 11-MAR-2021, the subject experienced body aches. On 11-MAR-2021, the subject experienced injection site arm pain. On 11-MAR-2021, the subject experienced pain in fingertips. On 11-MAR-2021, the subject experienced neck pain. On 11-MAR-2021, the subject experienced chest pain. On 11-MAR-2021, the subject experienced back pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches on 11-MAR-2021, and had not recovered from injection site arm pain, pain in fingertips, neck pain, chest pain, and back pain. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: BODY ACHES; INJECTION SITE ARM PAIN; PAIN IN FINGERTIPS; NECK PAIN; CHEST PAIN; BACK PAIN; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802070, and batch number: 1802070 expiry: UNKNOWN) dose was not reported, once a total in left deltoid administered on 10-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 11-MAR-2021, the subject experienced body aches. On 11-MAR-2021, the subject experienced injection site arm pain. On 11-MAR-2021, the subject experienced pain in fingertips. On 11-MAR-2021, the subject experienced neck pain. On 11-MAR-2021, the subject experienced chest pain. On 11-MAR-2021, the subject experienced back pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches on 11-MAR-2021, and had not recovered from injection site arm pain, pain in fingertips, neck pain, chest pain, and back pain. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Pyrexia
Clinical narrative: CHILLS; FEVER; HEADACHE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 10-MAR-2021 18:30 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 11-MAR-2021, the subject experienced chills. On 11-MAR-2021, the subject experienced fever. On 11-MAR-2021, the subject experienced headache. Laboratory data included: Body temperature (NR: not provided) 99.7 F, 101 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, headache, and chills. This report was non-serious.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Diarrhoea, Headache, Nausea, Vomiting
Clinical narrative: Severe nausea; Vomiting; Diarrhea; Headache; Low energy; This spontaneous report received from a patient concerned a 70 year old female. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: UNKNOWN expiry: UNKNOWN) .5 ml, administered on 08-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 09-MAR-2021, the subject experienced headache. On 09-MAR-2021, the subject experienced low energy. On 10-MAR-2021, the subject experienced severe nausea. On 10-MAR-2021, the subject experienced vomiting. On 10-MAR-2021, the subject experienced diarrhea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from low energy, severe nausea, vomiting, and diarrhea on MAR-2021, and had not recovered from headache. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pyrexia
Clinical narrative: FEVER; HEADACHE; MUSCLE ACHE; This spontaneous report received from a patient concerned a 74 year old female. The patient's weight was 159 pounds, and height was not reported. The patient's concurrent conditions included prediabetes, high cholesterol, overweight, non alcoholic, and non smoker, and other pre-existing medical conditions included the patient had no known allergies and no drug abuse or drug illicit use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805031, and batch number: 1805031 expiry: UNKNOWN) .5 ml, administered on 11-MAR-2021 12:30 for prophylactic vaccination. No concomitant medications were reported. On 11-MAR-2021, the subject experienced fever. On 11-MAR-2021, the subject experienced headache. On 11-MAR-2021, the subject experienced muscle ache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, headache, and muscle ache. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: FEVER; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802072, and batch number: 1802072 expiry: 25-MAY-2021) dose was not reported, administered on 10-MAR-2021 to Left Arm for prophylactic vaccination. No concomitant medications were reported.  On 11-MAR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 100.8 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of fever was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19, UNK
Symptoms: Adverse drug reaction
Clinical narrative: MILD SIDE EFFECTS; This spontaneous report received from a consumer via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: UNKNOWN expiry: UNKNOWN) .5 ml, administered on 09-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. Non-company suspect drugs included: naproxen sodium ( form of admin, route of admin, and batch number were not reported) dose, frequency, and therapy dates were not reported for an unspecified indication. No concomitant medications were reported. On MAR-2021, the subject experienced mild side effects. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of mild side effects was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Myalgia, Pyrexia
Clinical narrative: FEVER; CHILLS; MUSCLE ACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included hypertensive. The patient received covid-19 vaccine ad26.cov2.s (suspension for infusion, intramuscular, batch number: Unknown, and batch number: UNKNOWN expiry: UNKNOWN) .5 ml, administered on 10-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 10-MAR-2021, the subject experienced fever. On 10-MAR-2021, the subject experienced chills. On 10-MAR-2021, the subject experienced muscle ache. Laboratory data included: Body temperature (NR: not provided) 102 F, 103 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, chills, and muscle ache. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea, Pain, Pyrexia
Clinical narrative: BODY ACHE; CHILLS; FEVER; HEADACHE; NAUSEA; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) .5 ml, administered on 09-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 09-MAR-2021, the patient experienced body ache, chills, fever, headache and nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the body ache, chills, fever, headache and nausea was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Headache, Injection site pain, Pyrexia
Clinical narrative: Chills; Fever; Headache; brain fog; INJECTION SITE PAIN; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: UNKNOWN expiry: UNKNOWN) .5 ml, administered on 08-MAR-2021 23:21 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the subject experienced injection site pain. On 09-MAR-2021, the subject experienced headache. On 09-MAR-2021, the subject experienced brain fog. On 09-MAR-2021 10:30, the subject experienced chills. On 09-MAR-2021 10:30, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, fever, headache, and brain fog on 10-MAR-2021, and had not recovered from injection site pain. This report was non-serious. This case, from the same reporter is linked to 20210322560.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Migraine, Pain, Pyrexia
Clinical narrative: BODY ACHES; MIGRAINE; CHILLS; HEADACHE; FEVER; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 62876897/180529, and batch number: 62876897/180529 expiry: UNKNOWN) .5 ml, administered on 10-MAR-2021 09:30 for prophylactic vaccination. No concomitant medications were reported. On 11-MAR-2021, the subject experienced headache. On 11-MAR-2021, the subject experienced migraine. On 11-MAR-2021, the subject experienced fever. On 11-MAR-2021, the subject experienced chills. On 11-MAR-2021, the subject experienced body aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever, and chills, and had not recovered from headache, migraine, and body aches. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: HEADACHE; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown, and batch number: UNKNOWN expiry: UNKNOWN) .5 ml, administered on 07-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 07-MAR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from headache on 09-MAR-2021. This report was non-serious.